Prism Johnson Limited has submitted to the Exchange, the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026.
PRSMJOHNSN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.4 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Prism Johnson Limited reported FY2026 standalone net sales of Rs 7,254 crore, up 8.3% from Rs 6,697 crore in FY2025, driven by growth across Cement (Rs 3,405 crore, +12.7%), HRJ (Rs 2,392 crore, +3.6%), and RMC (Rs 1,534 crore, +8.5%) segments. However, Q4 standalone results showed a net loss of Rs 47.44 crore compared to a profit of Rs 133.73 crore in Q4 FY25, primarily due to an exceptional impairment charge of Rs 79.03 crore on the investment in Raheja QBE General Insurance Company (classified as held for sale). Full year standalone PAT declined 44% to Rs 55.99 crore from Rs 100.25 crore. Operating margins compressed to 8.06% in Q4 from 9.43% in Q4 FY25. The company generated positive operating cash flow of Rs 535.66 crore. Auditors issued an unmodified (clean) opinion on both standalone and consolidated results.
The stock may see mixed reaction as strong revenue growth is offset by a significant PAT decline and Q4 loss due to exceptional impairment charges. Margin compression and weaker profitability could concern investors, though the Rs 79 crore impairment is a one-time item and the company maintains positive cash flows.